- Home
- ABCL vs TGB Comparison
ABCL vs TGB Comparison
Compare ABCL & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABCL | TGB |
|---|---|---|
| Founded | 2012 | 1966 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.2B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ABCL | TGB |
|---|---|---|
| Price | $13.27 | $8.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $16.70 | $9.76 |
| AVG Volume (30 Days) | 4.4M | ★ 4.7M |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,128,000.00 | N/A |
| Revenue This Year | N/A | $81.21 |
| Revenue Next Year | $7.91 | $24.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $3.66 |
| 52 Week High | $14.98 | $9.82 |
Technical Indicators
Market Signals| Indicator | ABCL | TGB |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 53.48 |
| Support Level | $10.38 | $6.32 |
| Resistance Level | N/A | $9.15 |
| Average True Range (ATR) | 0.77 | 0.39 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 58.85 | 67.81 |
Price Performance
Historical ComparisonAbout ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
About TGB Taseko Mines Ltd.
Trekor Metals Ltd is a North American copper producer with a development pipeline of minerals projects and properties in Canada and the United States. The company's properties include Gibraltar Mine, Florence Copper, Yellowhead Project, Aley Project, and New Prosperity.